Pharmaceutical slaves rejoice, for the overlords in our Brave New World have devised new drugs currently in the pipeline to treat the side effects of their old drugs.
This is all totally about promoting human health and not cynical profiteering and further sickening the population to make it more dependent on a constant stream of patented new drugs; claims to the contrary are disrespectful to The Science™, and the likes of Anthony Fauci won’t stand for it.
Related: ‘Ozempic Face’ Destroying the Hollywood Beautiful People?
Via Irish Examiner (emphasis added):
The new blockbuster weight loss shots can help patients trim more pounds than any medicines have before. Now drugmakers are rushing to solve another problem — making sure people keep their muscle even as they shed fat.
The race for potential treatments is picking up pace. Regeneron Pharmaceuticals released data recently showing that its antibody cocktail boosted muscle in a small group of volunteers. Eli Lilly & Co agreed to shell out as much as $2bn (€1.8bn) last year for a startup with an experimental drug that aims to decrease fat while maintaining muscle.
Some doctors are sceptical, saying that for many obese patients shedding pounds is of paramount importance, even if they lose muscle alongside fat. Yet preserving muscle is an alluring goal for drugmakers that missed the first generation of obesity treatments and are seeking a foothold in the fast-growing and lucrative field…
When people drop weight very quickly, whether via obesity drugs or bariatric surgery, they may face a higher risk of an unhealthy loss of muscle. And if they stop using the drugs and regain weight, they risk adding back a higher proportion of fat, an effect that can weaken the body over time.
The phenomenon is rooted in the body’s ability to raid its own muscles to survive periods of starvation, said George Yancopoulos, chief scientific officer of Regeneron. Severe caloric restriction helps spur the production of myostatin, a protein that impedes the growth of muscle.
For what it’s worth, I had previously written for PJ Media many moons ago now about this exact side effect of semaglutide drugs — essentially putting the body into starvation mode and triggering it to cannibalize its muscle tissue — which have been known for many years and which are totally predictable given a surface-level understanding of what these injections do and how GLP-1 agonists work.
Via Insider (emphasis added):
The popular new weight-loss medication semaglutide is helping people shed weight — but it can also cause a major loss of muscle mass, according to a doctor.
Semaglutide has been described as a “game changer” for treating obesity and was FDA-approved for weight loss in 2021* under the brand name Wegovy. It’s also available as Ozempic, which is the same medication, but sold to treat type 2 diabetes (although doctors can and do prescribe it for weight loss as well).
Semaglutide works by mimicking a natural hormone in the body that helps regulate blood sugar, digestion, and hunger.
But the FDA, and success stories of semaglutide, doesn’t account for patients who are also losing lean muscle, which could worsen their health long-term, Dr. Peter Attia said in a recent clip of his podcast “The Drive.”
Attia said body composition, or the ratio of muscle to fat, is a more helpful measure of weight loss results (and subsequent health improvements) than purely the number of pounds lost.
Attia also noted a trend of people without type 2 diabetes or a high body fat percentage who want to use the medication for small amounts of aesthetic weight loss.
“Perhaps more disturbing to me is the people who are reaching out to me who are frankly not overweight remotely but are saying ‘I really want to lose 10 pounds to look good on my vacation, I should be taking this, right?'” he said.
Attia said in an earlier post that his patients who have used semaglutide lost weight effectively, but not all of it was body fat.
“They’ve lost muscle mass at a rate that alarms me,” he said.
*The New England Journal of Medicine study cited as the justification for pushing these drugs on obese patients, in fact, did not distinguish between muscle loss and fat loss in its study, leaving the deceptive conclusion that these drugs shed excess body fat when in reality they shed fat and precious muscle and cause a host of side effects that went undocumented as well.
Free lunches don’t exist.There is no physical reality in which injecting oneself with an artificial form of a hormone, disrupting the entire delicate endocrine system balance in the process, is going to be a magical cure-all for obesity or any other problem.
There are going to be downstream detrimental consequences, to be reaped in due time.
The piper will be paid.
